Advertisement

Alector, Inc. ALEC

Set alert

Price alert · ALEC

All alert types
2.21 USD -0.03 -1.34%

At close · Oct 30

2.13 -0.08 -3.62%

After hours · Oct 30, 5:30 PM ET

Bid
2.19 × 2
Ask
2.20 × 2
2.09 Day range 2.25
1.14 52-week range 2.72
YTD
+41.67%
1 year
+45.39%
Open
2.20
Prev close
2.24
Mkt cap
246.76M
Vol
1.11M
Avg vol
3.32M
EPS
-1.09
P/E
0.00
Div yield
0.00%
More statistics
Low
2.09
High
2.25
Forward P/E
-1.25
Beta
0.66
Short ratio
3.92
Inst. own
95.87%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2024
50-d avg
3.81
200-d avg
4.92
1y target
5.51

MAX chart

Chart tools
Interval

Events in this range
  • Feb 27, 2024Earnings: -0.49; estimate -0.8; surprise 38.75%
  • May 8, 2024Earnings: -0.38; estimate -0.48; surprise 20.83%
  • May 8, 2024Earnings: —; estimate -0.48; surprise —%
  • Aug 7, 2024Earnings: -0.4; estimate -0.49; surprise 18.37%
  • Aug 7, 2024Earnings: —; estimate -0.49; surprise —%
  • Sep 17, 2024Rating: Cantor Fitzgerald · — → Overweight
  • Nov 6, 2024Earnings: -0.43; estimate -0.53; surprise 18.87%
  • Nov 7, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Nov 26, 2024Rating: Cantor Fitzgerald · — → Overweight
  • Nov 26, 2024Rating: BTIG · Buy → Buy
  • Nov 26, 2024Downgrade: Morgan Stanley · Equal-Weight → Underweight
  • Dec 16, 2024Downgrade: Stifel · Buy → Hold
Signals (160)
NameDateAgo
SMA: BullishOct 26, 20266 days ago
SMA: BullishOct 26, 20266 days ago
MACD: Buy SignalOct 26, 20266 days ago
SMA: BearishOct 12, 20262 weeks ago
MACD: Sell SignalOct 12, 20262 weeks ago
SMA: BullishOct 5, 20263 weeks ago
SMA: BearishSep 14, 20261 month ago
SMA: BearishSep 14, 20261 month ago
SMA: BullishAug 17, 20262 months ago
MACD: Buy SignalAug 17, 20262 months ago
SMA: BullishAug 3, 20263 months ago
SMA: BearishJul 6, 20263 months ago
SMA: BearishJul 6, 20263 months ago
SMA: BullishJun 29, 20264 months ago
SMA: BullishJun 29, 20264 months ago
SMA: BearishJun 1, 20265 months ago
MACD: Sell SignalMay 25, 20265 months ago
SMA: BearishMay 4, 20266 months ago
SMA: BullishMar 30, 20267 months ago
SMA: BullishMar 30, 20267 months ago
SMA: BearishMar 23, 20267 months ago
SMA: BearishMar 23, 20267 months ago
SMA: BullishMar 9, 20267 months ago
SMA: BearishMar 2, 20268 months ago
SMA: BullishFeb 23, 20268 months ago
MACD: Buy SignalJan 19, 20269 months ago
SMA: BullishDec 22, 202510 months ago
MACD: Sell SignalOct 27, 20251 year ago
SMA: BearishOct 20, 20251 year ago
SMA: BearishOct 20, 20251 year ago
SMA: BullishAug 4, 20251 year ago
SMA: BearishJul 28, 20251 year ago
SMA: BullishJun 30, 20251 year ago
SMA: BullishMay 12, 20251 year ago
SMA: BearishMay 5, 20251 year ago
SMA: BullishApr 28, 20251 year ago
RSI: OversoldMar 24, 20251 year ago
SMA: BearishFeb 24, 20251 year ago
MACD: Buy SignalFeb 24, 20251 year ago
SMA: BullishFeb 17, 20251 year ago
RSI: OversoldDec 16, 20241 year ago
SMA: BearishNov 11, 20241 year ago
SMA: BearishNov 11, 20241 year ago
MACD: Sell SignalNov 11, 20241 year ago
SMA: BullishNov 4, 20241 year ago
SMA: BullishNov 4, 20241 year ago
MACD: Buy SignalNov 4, 20241 year ago
MACD: Sell SignalOct 7, 20242 years ago
SMA: BearishSep 23, 20242 years ago
SMA: BearishSep 23, 20242 years ago
SMA: BullishSep 9, 20242 years ago
SMA: BullishSep 9, 20242 years ago
SMA: BearishAug 26, 20242 years ago
SMA: BullishAug 19, 20242 years ago
SMA: BearishJul 29, 20242 years ago
SMA: BullishJul 15, 20242 years ago
MACD: Buy SignalJul 15, 20242 years ago
SMA: BullishJul 8, 20242 years ago
MACD: Sell SignalMar 18, 20242 years ago
SMA: BearishMar 11, 20242 years ago
SMA: BearishMar 11, 20242 years ago
SMA: BullishFeb 26, 20242 years ago
SMA: BullishFeb 19, 20242 years ago
SMA: BearishFeb 12, 20242 years ago
SMA: BullishFeb 5, 20242 years ago
SMA: BearishJan 15, 20242 years ago
SMA: BearishJan 15, 20242 years ago
SMA: BullishDec 11, 20232 years ago
MACD: Buy SignalDec 4, 20232 years ago
SMA: BullishNov 27, 20232 years ago
MACD: Sell SignalOct 16, 20233 years ago
SMA: BearishSep 25, 20233 years ago
SMA: BearishSep 25, 20233 years ago
SMA: BullishSep 18, 20233 years ago
SMA: BullishSep 18, 20233 years ago
MACD: Buy SignalSep 18, 20233 years ago
MACD: Sell SignalAug 28, 20233 years ago
SMA: BearishAug 21, 20233 years ago
SMA: BearishAug 14, 20233 years ago
SMA: BullishJul 31, 20233 years ago
SMA: BullishJul 31, 20233 years ago
SMA: BearishJun 19, 20233 years ago
SMA: BullishMay 1, 20233 years ago
MACD: Buy SignalMay 1, 20233 years ago
MACD: Sell SignalMar 6, 20233 years ago
SMA: BearishFeb 20, 20233 years ago
SMA: BearishFeb 20, 20233 years ago
SMA: BullishFeb 13, 20233 years ago
SMA: BullishJan 23, 20233 years ago
SMA: BearishJan 16, 20233 years ago
SMA: BullishJan 9, 20233 years ago
SMA: BearishJan 2, 20233 years ago
SMA: BullishNov 28, 20223 years ago
MACD: Buy SignalNov 28, 20223 years ago
MACD: Sell SignalNov 21, 20223 years ago
SMA: BearishOct 31, 20224 years ago
SMA: BullishOct 24, 20224 years ago
SMA: BearishAug 22, 20224 years ago
SMA: BearishAug 15, 20224 years ago
SMA: BullishAug 1, 20224 years ago
SMA: BullishJun 20, 20224 years ago
MACD: Buy SignalJun 20, 20224 years ago
RSI: OversoldJun 6, 20224 years ago
RSI: OversoldApr 25, 20224 years ago
SMA: BearishDec 27, 20214 years ago
SMA: BullishDec 13, 20214 years ago
SMA: BearishNov 8, 20214 years ago
SMA: BearishNov 8, 20214 years ago
SMA: BullishNov 1, 20215 years ago
SMA: BullishNov 1, 20215 years ago
SMA: BearishOct 25, 20215 years ago
SMA: BullishOct 18, 20215 years ago
SMA: BearishOct 11, 20215 years ago
MACD: Sell SignalAug 23, 20215 years ago
SMA: BearishAug 16, 20215 years ago
SMA: BullishAug 2, 20215 years ago
SMA: BearishJul 26, 20215 years ago
RSI: OverboughtJun 28, 20215 years ago
MACD: Buy SignalJun 7, 20215 years ago
SMA: BullishMay 31, 20215 years ago
SMA: BearishMay 3, 20215 years ago
MACD: Sell SignalMay 3, 20215 years ago
SMA: BullishApr 19, 20215 years ago
SMA: BearishApr 5, 20215 years ago
SMA: BullishMar 29, 20215 years ago
SMA: BearishMar 22, 20215 years ago
SMA: BullishMar 8, 20215 years ago
SMA: BearishMar 1, 20215 years ago
SMA: BullishJan 4, 20215 years ago
MACD: Buy SignalNov 9, 20205 years ago
SMA: BullishNov 2, 20206 years ago
SMA: BearishJun 22, 20206 years ago
SMA: BearishJun 22, 20206 years ago
MACD: Sell SignalJun 22, 20206 years ago
MACD: Buy SignalMay 18, 20206 years ago
SMA: BullishMay 4, 20206 years ago
MACD: Sell SignalMar 30, 20206 years ago
SMA: BearishMar 23, 20206 years ago
SMA: BullishMar 16, 20206 years ago
SMA: BearishMar 9, 20206 years ago
RSI: OverboughtJan 27, 20206 years ago
SMA: BullishJan 6, 20206 years ago
SMA: BullishJan 6, 20206 years ago
SMA: BearishDec 23, 20196 years ago
SMA: BearishDec 23, 20196 years ago
SMA: BullishNov 25, 20196 years ago
SMA: BullishNov 25, 20196 years ago
SMA: BearishNov 11, 20196 years ago
SMA: BullishOct 28, 20197 years ago
MACD: Buy SignalOct 28, 20197 years ago
MACD: Sell SignalSep 30, 20197 years ago
SMA: BearishSep 23, 20197 years ago
SMA: BearishSep 23, 20197 years ago
SMA: BullishSep 16, 20197 years ago
SMA: BullishSep 9, 20197 years ago
SMA: BearishAug 5, 20197 years ago
SMA: BullishJul 15, 20197 years ago
SMA: BearishJul 8, 20197 years ago
SMA: BullishJul 1, 20197 years ago
SMA: BearishApr 29, 20197 years ago

Key statistics

Market cap
181.18M
Enterprise value
-240.41M
Trailing P/E
0.00
Forward P/E
-1.25
PEG ratio
0.00
Price / sales
2.95
Price / book
1.52
EPS (TTM)
-1.71
Beta
0.66
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-257.54%
Revenue (TTM)
61.51M
Revenue growth
68.40%
Free cash flow
-66.92M
Total cash
457.20M
Total debt
34.64M
Return on equity
-112.55%
Shares outstanding
97.93M
Short % of float
7.83%
50-day average
3.81
200-day average
4.92

Analyst view

Consensus: buy

Buy
Price target (mean) 5.51 +149.4% upside
Target (low)
1.00
Target (mean)
5.51
Target (high)
12.00
Ratings (0m) 10 7 buy · 1 hold · 2 sell
  • Strong buy2
  • Buy5
  • Hold1
  • Sell1
  • Strong sell1

Next earnings

Aug 7, 2024

Expected Aug 7, 2024. Consensus EPS estimate -0.53686.

Earnings history

Financials — quick view

All financials
ALEC Revenue — quarterly 3.32M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ALEC Net income — quarterly -22.99M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ALEC EPS — quarterly -0.21
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

ALEC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 6, 2024Sep 1, 2024-0.53-0.43+0.10+18.87%
Aug 7, 2024Jun 1, 2024-0.49-0.40+0.09+18.37%
Aug 7, 2024Jun 1, 2024-0.49———
May 8, 2024Mar 1, 2024-0.48-0.38+0.10+20.83%
May 8, 2024Mar 1, 2024-0.48———
Feb 27, 2024Dec 1, 2023-0.80-0.49+0.31+38.75%

Upgrades / downgrades

ALEC analyst upgrades and downgrades
DateFirmActionFromTo
Dec 16, 2024StifeldownBuyHold
Nov 26, 2024Morgan StanleydownEqual-WeightUnderweight
Nov 26, 2024BTIGmainBuyBuy
Nov 26, 2024Cantor Fitzgeraldreit—Overweight
Nov 7, 2024HC Wainwright & Co.reitBuyBuy
Sep 17, 2024Cantor Fitzgeraldreit—Overweight

About Alector, Inc.

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, an immune activity in the brain with genetic links to multiple neurodegenerative disorders, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Website
alector.com

News

Your note

Sign in to keep a note on ALEC — it syncs with the Stock Master app.

Insider holders

ALEC insider holders
InsiderRelationLatest transactionDateShares held
GAROFALO ELIZABETH A.DirectorStock Award(Grant)Jun 11, 202461,250
GRASSO MARCChief Financial OfficerSaleDec 1, 2024330,651
HAMMOND PAULADirectorSaleAug 11, 202460,209
KENKARE-MITRA SARASWATIOfficerSaleDec 1, 2024565,215
LAVIGNE LOUIS J JRDirectorStock Award(Grant)Jun 11, 202481,261
ROMANO GARYOfficerSaleDec 1, 2024349,283

Institution ownership

ALEC institution ownership
Holder% heldSharesValueReported
FMR, LLC14.90%14,595,01427.00MSep 29, 2024
Blackrock Inc.9.55%9,352,04417.30MSep 29, 2024
Vanguard Group Inc5.57%5,455,72710.09MSep 29, 2024
Deep Track Capital, Lp4.73%4,631,9988.57MSep 29, 2024
Morgan Stanley4.45%4,355,7708.06MSep 29, 2024
JP Morgan Chase & Company2.79%2,728,8235.05MSep 29, 2024

Fund ownership

ALEC fund ownership
Holder% heldSharesValueReported
Fidelity Growth Company Fund3.71%3,637,3696.73MOct 30, 2024
Fidelity Select Portfolios - Biotechnology3.61%3,535,7536.54MOct 30, 2024
Vanguard Total Stock Market Index Fund2.42%2,365,5714.38MSep 29, 2024
iShares Russell 2000 ETF2.14%2,098,3413.88MOct 30, 2024
JP Morgan Small Cap Growth Fund1.54%1,506,6112.79MSep 29, 2024
Fidelity Growth Company K6 Fund1.30%1,268,9312.35MOct 30, 2024
Advertisement